Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Salarius Pharmaceuticals (SLRX.US)$ Salarius Pharmaceuticals Notified By MD Anderson Cancer Center Of Grade 4 Adverse Event In Seclidemstat Clinical Trial; FDA Places Trial On Partial Clinical Hold; No New Patients Enrolled, Current Patients May Continue Treatment; Company To Support Data Analysis And Respond To FDA Queries
- 8K Filing
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
2
Translate
Report
5213 Views